Banque Cantonale Vaudoise’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.57M | Buy |
51,841
+19,827
| +62% | +$2.13M | 0.23% | 84 |
|
|
2025
Q1 | $3.23M | Buy |
+32,014
| New | +$3.23M | 0.14% | 141 |
|
|
2024
Q3 | $2.63M | Buy |
31,402
+4,169
| +15% | +$349K | 0.11% | 201 |
|
|
2024
Q2 | $2.1M | Buy |
27,233
+668
| +3% | +$51.4K | 0.08% | 226 |
|
|
2024
Q1 | $1.82M | Buy |
26,565
+886
| +3% | +$60.7K | 0.07% | 265 |
|
|
2023
Q4 | $1.48M | Sell |
25,679
-23,748
| -48% | -$1.37M | 0.06% | 280 |
|
|
2023
Q3 | $2.61M | Buy |
49,427
+8,625
| +21% | +$455K | 0.13% | 131 |
|
|
2023
Q2 | $2.21M | Buy |
40,802
+1,315
| +3% | +$71.1K | 0.1% | 172 |
|
|
2023
Q1 | $1.97M | Sell |
39,487
-187
| -0.5% | -$9.35K | 0.1% | 203 |
|
|
2022
Q4 | $1.84M | Sell |
39,674
-3,225
| -8% | -$149K | 0.1% | 200 |
|
|
2022
Q3 | $1.66M | Sell |
42,899
-213
| -0.5% | -$8.25K | 0.09% | 207 |
|
|
2022
Q2 | $1.61M | Sell |
43,112
-37
| -0.1% | -$1.38K | 0.08% | 232 |
|
|
2022
Q1 | $1.91M | Sell |
43,149
-2,894
| -6% | -$128K | 0.08% | 235 |
|
|
2021
Q4 | $1.96M | Buy |
46,043
+11,533
| +33% | +$490K | 0.08% | 243 |
|
|
2021
Q3 | $1.5M | Sell |
34,510
-3,990
| -10% | -$173K | 0.06% | 314 |
|
|
2021
Q2 | $1.65M | Sell |
38,500
-8,734
| -18% | -$373K | 0.07% | 278 |
|
|
2021
Q1 | $1.83M | Sell |
47,234
-2,254
| -5% | -$87.1K | 0.09% | 211 |
|
|
2020
Q4 | $1.78M | Buy |
49,488
+4,700
| +10% | +$169K | 0.1% | 186 |
|
|
2020
Q3 | $1.71M | Buy |
44,788
+3,387
| +8% | +$129K | 0.11% | 171 |
|
|
2020
Q2 | $1.45M | Buy |
41,401
+17,634
| +74% | +$619K | 0.11% | 190 |
|
|
2020
Q1 | $775K | Buy |
23,767
+1,676
| +8% | +$54.7K | 0.07% | 280 |
|
|
2019
Q4 | $998K | Buy |
+22,091
| New | +$998K | 0.07% | 293 |
|